États-Unis · Plateformes & données · Finviz

Karyopharm Therapeutics Files for Chapter 11 Bankruptcy and Agrees to Planned Merger with Ayrmid

Publié par Finviz · États-Unis il y a 10 h

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) has filed for Chapter 11 bankruptcy protection and entered into a restructuring agreement that provides for a proposed merger with…

Lire l'article complet sur Finviz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (finviz.com)

Karyopharm Therapeutics Files for Chapter 11 Bankruptcy and Agrees to Planned Merger with Ayrmid

À lire aussi

Insider Selling: Corporacion Inmobiliaria Vesta (NYSE:VTMX) Insider Sells 3,814 Shares of Stock

These 2 Tech Stocks Both Fell 29% on Friday. Are They Buying Opportunities Now?

It may take weeks to tally the midterm election results. Here’s why Wall Street isn’t worried.

Ryanair ADR earnings beat by $0.02, revenue fell short of estimates

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

RBC Q3 deep dive: Aerospace & Defense demand, industrial strength, and marine constraints shape outlook

Karyopharm Therapeutics Files for Chapter 11 Bankruptcy and Agrees to Planned Merger with Ayrmid

Partager

À lire aussi

Insider Selling: Corporacion Inmobiliaria Vesta (NYSE:VTMX) Insider Sells 3,814 Shares of Stock

These 2 Tech Stocks Both Fell 29% on Friday. Are They Buying Opportunities Now?

It may take weeks to tally the midterm election results. Here’s why Wall Street isn’t worried.

Ryanair ADR earnings beat by $0.02, revenue fell short of estimates

Toncoin (TON) Price Prediction 2025, 2026, 2027-2030

RBC Q3 deep dive: Aerospace & Defense demand, industrial strength, and marine constraints shape outlook